Oncoinvent A

Oncoinvent A EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Oncoinvent A (ONCIN.OL) as of Nov 7, 2026 is -0.12. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -0.34 — a change of -65.34% (higher).

EV/FCF

-0.12

YoY

-65.34%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Oncoinvent A is 2025 -0.12 . EV/FCF (Enterprise Value to Free Cash Flow) of Oncoinvent A was 2024 -0.34 . It decreases by -65.34% higher compared to the previous year.

The Oncoinvent A EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
0.90 NOK
Jan 1, 2019
0.33 NOK
Jan 1, 2020
2.25 NOK
Jan 1, 2021
-0.64 NOK
Jan 1, 2022
-0.14 NOK
Jan 1, 2023
-0.22 NOK
Jan 1, 2024
-0.34 NOK
Jan 1, 2025
-0.12 NOK
The Oncoinvent A EV/FCF history
YEAREV/FCFYoY
-0.12-65.34%
-0.34+56.69%
-0.22+52.32%
-0.14-77.46%
-0.64-128.36%
2.25+587.87%
0.33-63.59%
0.90-14.92%
1.06-527.95%
-0.25-87.04%
-1.90—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Oncoinvent A Stock analysis

What does Oncoinvent A do? Oncoinvent ASA is a radiopharmaceutical company based in Oslo, Norway, operating within the Health Care sector. Listed on 13 December 2024, the firm employs 46 people and focuses on developing alpha-emitting radiotherapeutics for cancer patients. Its primary product, Radspherin, is an alpha-emitting radioactive microsphere therapy designed to treat metastatic cancers in body cavities. This suspension of calcium carbonate microspheres labelled with Radium-224 targets residual micro-metastases on intracavitary surfaces and in liquids after surgery, aiming to spare deeper organs from harmful radiation doses. Oncoinvent A is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Oncoinvent A stock

EV/FCF (Enterprise Value to Free Cash Flow) of Oncoinvent A is -0.12 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Oncoinvent A changed from -0.34 to -0.12, representing a -65.34% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Oncoinvent A since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Oncoinvent A with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Oncoinvent A

All Key Metrics — Oncoinvent A